CLOUDBREAK PHARMA INC. - B
(HKEX: 2592)
Cloudbreak Pharma, Inc. is an investment holding company, which engages in the research and development of therapeutic biologics. Its pipeline includes CBT-001, CBT-009, CBT-004, CBT-006, CBT-199, CBT-145, CBT-007, and CBT-011. The company was founded by Jin Song Ni, Van Son Dinh, and Jun Zhi Li in September 2015 and is headquartered in Irvine, CA.
1.450 -
+0.040
(+2.84%)
Range
1.410 - 1.480
(4.96%)
Open
1.410
Previous Close
1.410
Bid Price
1.410
Bid Volume
('000)
16
Ask Price
1.440
Ask Volume
('000)
39
Volume
('000)
212
Value
302,515
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
